title: Inflammatory immune cell responses and Toll-like receptor expression in synovial tissues in rheumatoid arthritis patients treated with biologics or DMARDs.
abstract: Biologic antirheumatic drugs (BIO) have been reported to be potent therapeutic agents in the prevention of inflammatory joint destruction in rheumatoid arthritis (RA). The aim of this study was to investigate the immune-inflammatory cells, including Toll-like receptor (TLR)-equipped cells, in synovial tissue samples from RA patients on BIO compared to patients, who are only on conventional disease-modifying antirheumatic drug (DMARD). We analyzed immune-inflammatory cells in RA synovitis in patients of BIO group (n = 20) or DMARD group (n = 20). The grading scores of synovitis was 1.7 and 1.8 in each BIO and DMARD group and correlated best with the CD3(+) T (r = 0.71/0.70, p < 0.05) and CD20(+) B (r = 0.80/0.84, p < 0.05) cells in the both groups, but less well with the CD68(+) macrophages and S-100(+) dendritic cells (DCs). Interestingly, both T (116 vs. 242, p < 0.05) and B (80 vs. 142, p < 0.05) cell counts were lower in the BIO than in the DMARD group, whereas macrophage and DC counts did not differ. In contrast, the C-reactive protein (CRP) and disease activity score DAS28-CRP did not show clear-cut correlations with the inflammatory grade of the synovitis (r range, 0-0.35). Similar numbers of cells immunoreactive for TLR-1 to TLR-6 and TLR-9 were found in synovitis in both groups. Patients clinically responding to biologics might still have the potential of moderate/severe local joint inflammation, composed in particular of and possibly driven by the autoinflammatory TLR(+) cells.
authors: Department of Orthopedic Surgery, Yamagata University School of Medicine, 2-2-2 Iida Nishi, Yamagata 990-9585, Japan. takakubo-y@med.id.yamagata-u.ac.jp
authors: Yuya
authors: Y
authors: Takakubo
authors: Yasunobu
authors: Y
authors: Tamaki
authors: Tomoyuki
authors: T
authors: Hirayama
authors: Kiyoshi
authors: K
authors: Iwazaki
authors: Kan
authors: K
authors: Sasaki
authors: Akiko
authors: A
authors: Sasaki
authors: Hiroharu
authors: H
authors: Ohki
authors: Noe
authors: N
authors: Takakubo
authors: Yrjö T
authors: YT
authors: Konttinen
authors: Michiaki
authors: M
authors: Takagi
mesh_terms: D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000276:immunology; D001688:Biological Products / Q000627:therapeutic use*; D003713:Dendritic Cells / Q000166:cytology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007249:Inflammation / Q000276:immunology* / Q000473:pathology; D008264:Macrophages / Q000166:cytology; D008297:Male; D008875:Middle Aged; D013582:Synovial Fluid / Q000276:immunology*; D013583:Synovial Membrane / Q000378:metabolism; D013585:Synovitis / Q000378:metabolism; D051193:Toll-Like Receptors / Q000378:metabolism*
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products; D051193:Toll-Like Receptors
references: Ann Rheum Dis. 2009 May;68(5):751-6
references: 18495732
references: Arthritis Rheum. 1995 Jun;38(6):727-35
references: 7779114
references: Curr Rheumatol Rep. 2009 Oct;11(5):357-64
references: 19772831
references: J Rheumatol. 2009 Mar;36(3):598-608
references: 19208601
references: Ann Rheum Dis. 2011 Mar;70(3):423-7
references: 21109518
references: Nat Rev Rheumatol. 2009 Oct;5(10):566-71
references: 19798032
references: J Pathol. 2005 Apr;205(5):565-76
references: 15714595
references: Arthritis Res Ther. 2009;11(5):249
references: 19835638
references: Arthritis Rheum. 2007 Sep;56(9):2957-67
references: 17763416
references: Pathol Res Pract. 2002;198(5):317-25
references: 12092767
references: Lancet. 2004 Feb 28;363(9410):675-81
references: 15001324
references: Ann Rheum Dis. 2010 Jun;69(6):1200-7
references: 19773288
references: Mod Rheumatol. 2005;15(1):4-8
references: 17028815
references: Arthritis Rheum. 2010 Jan;62(1):53-63
references: 20039433
references: N Engl J Med. 2000 Nov 30;343(22):1594-602
references: 11096166
references: Arthritis Rheum. 2004 May;50(5):1457-67
references: 15146415
references: Nature. 2003 May 15;423(6937):356-61
references: 12748655
references: Nat Immunol. 2001 Aug;2(8):675-80
references: 11477402
references: Nat Rev Rheumatol. 2010 Mar;6(3):146-56
references: 20142813
references: J Pathol. 2004 Sep;204(1):28-38
references: 15307135
references: Adv Exp Med Biol. 1995;378:317-9
references: 8526083
references: J Immunol. 2001 Aug 1;167(3):1758-68
references: 11466401
references: Ann Rheum Dis. 2009 Sep;68(9):1486-93
references: 18765427
references: Arthritis Rheum. 2005 Aug;52(8):2313-22
references: 16052591
references: J Rheumatol. 2008 Oct;35(10):1919-31
references: 18785315
references: Arthritis Rheum. 1998 Oct;41(10):1845-50
references: 9778226
references: Arthritis Rheum. 2004 Dec;50(12):3856-65
references: 15593217
references: Arthritis Rheum. 2005 Nov;52(11):3381-90
references: 16258899
references: Arthritis Rheum. 1995 Jan;38(1):44-8
references: 7818570
references: Mod Rheumatol. 2010 Apr;20(2):147-53
references: 20012459
references: Ann Rheum Dis. 2005 Nov;64(11):1532-8
references: 15878905